Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLI-ATG Conditioning for Older Patients with Relapsed Lymphoid Malignancies
NCT01566656Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Mar 2012
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in non-Hodgkin lymphoma (NHL), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, T-cell lymphoma, sponsored by CHU de Nantes. Started Mar 2012; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
non-Hodgkin lymphoma (NHL)mantle cell lymphoma (MCL)marginal zone lymphoma (MZL)extranodal marginal zone lymphoma of mucosa-associated lymphoid tissueT-cell lymphoma
Beyond the preview
Go deeper on NCT01566656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566656.